SARS and common viral infections

Janice K Louie; Jill K Hacker; Jennifer Mark; Shilpa S Gavali; Shigeo Yagi; Alex Espinosa; David P Schnurr; Cynthia K Cossen; Erin R Isaacson; Carol A Glaser; Marc Fischer; Arthur L Reingold; Duc J Vugia; Unexplained Deaths and Critical Illnesses Working Group

doi:10.3201/eid1006.030863

SARS and common viral infections

Emerg Infect Dis. 2004 Jun;10(6):1143-6. doi: 10.3201/eid1006.030863.

Authors

Janice K Louie¹, Jill K Hacker, Jennifer Mark, Shilpa S Gavali, Shigeo Yagi, Alex Espinosa, David P Schnurr, Cynthia K Cossen, Erin R Isaacson, Carol A Glaser, Marc Fischer, Arthur L Reingold, Duc J Vugia; Unexplained Deaths and Critical Illnesses Working Group

Affiliation

¹ California Emerging Infections Program, California Department of Health Services, Berkeley, 94704, USA. JLouie@dhs.ca.gov

Abstract

In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspected SARS and 9 (47%) of 19 patients with probable SARS.

MeSH terms

Antibodies, Viral / blood
California
Humans
RNA, Viral / chemistry
RNA, Viral / genetics
Respiratory Tract Infections / diagnosis*
Respiratory Tract Infections / virology
Reverse Transcriptase Polymerase Chain Reaction
Severe Acute Respiratory Syndrome / diagnosis*
Severe Acute Respiratory Syndrome / virology
Severe acute respiratory syndrome-related coronavirus / isolation & purification
Virus Diseases / diagnosis*
Virus Diseases / virology

Substances

Antibodies, Viral
RNA, Viral